Drugs
3 Observations in STAQ Pharma Inspection
FDA has released the Form FDA-483 with three observations from its 8/10-8/19 inspection at the STAQ Pharma Ohio outsourcing facility in Columbus, OH. The inspection observations were: * failure of laboratory controls to include the establishment of scientifically sound and appropriate specifications, standards, sampling plans, and test